Young-Adult viewership soars as HBCU Honors defies trends with major gains; expanded long-form now streaming on HBCU Honors YouTube. WASHINGTON, DC, UNITED STATES, December 31, 2025 /EINPresswire.com/ ...

Local anti-poverty groups have had to scramble and scale back this year as the Trump administration targeted safety-net ...

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension ...

The US government is launching an early career hiring and talent development program to bring more technology and artificial intelligence employees to the public sector, as part of the Trump ...

OU’s Academic Programs Council will consider adjusting eight degree programs to become 90-credit hour speciality degrees Friday. According to documents posted on the Academic Programs Council website, ...

TL;DR: Bungie faces a $200 million asset write-down by Sony due to Destiny 2's declining playerbase, dropping from 316,000 to 15,000 daily users. Despite this, early development of Destiny 3 is ...

Destiny 2 is in a quite frankly woeful spot. Its current The Edge of Fate expansion has been a complete bust, resulting in Bungie's space game's player count dwindling to record lows; a point I never ...

Aaron McKinley is a writer, blogger and video game enthusiast with over five years of experience in web content and many more in playing games until the wee hours of the morning. His work spans many ...

We might be a long way off from the game. For many players, Bungie might not be firing off as many successes as it did back in the day. We might be a good way off from those days, but they are still ...

Jacob S. Suissa receives funding from The National Science Foundation. He is affiliated with Arnold Arboretum of Harvard University, and Let's Botanize Inc. There are few forms of the botanical world ...

Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines for infectious diseases. The ...